Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Hepatocellular × S 1 (combination) × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1

Interventions

Sorafenib 8 gadolinium ethoxybenzyl DTPA 4 Hepatectomy 4 lenvatinib 3 Sufentanil 3 Ribavirin 3 Propranolol 3 sofosbuvir-velpatasvir drug combination 2 peginterferon alfa-2a 2 gadoterate meglumine 2 entecavir 2 Thrombectomy 2 Tenofovir 2 Sevoflurane 2 Lamivudine 2 Esketamine 2 Chemoembolization, Therapeutic 2 xihuang 1 stronger neominophagen C 1 ledipasvir 1 huaier 1 gadoteridol 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1 flurbiprofen axetil 1 fish oil triglycerides 1 contrast agent BR1 1 chlorhexidine gluconate 1 cantharidin methylimide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01997957 2013-11-28

SOON

Peking University Cancer Hospital & Institute

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡